Arm Is Betting on a World Where Everything Needs a Chip

Arm's stock has surged 160% this year and its first in-house chip already has billions in orders, yet one hard number keeps analysts from calling it a buy.

Published September 30, 2026, 2:00pm ET · 3 min read

Price Targets desk. Editor: Vandita Jadeja.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

A close-up shot of a green and yellow gradient circuit board filled with various electronic components. Bright blue-white glowing points on several microchips and other components are interconnected by thin, arcing white lines, symbolizing data flow and networking. The depth of field highlights the foreground elements against a softly blurred background.
This image symbolizes the intricate networks and widespread integration of semiconductor chips, reflecting Arm's strategic position in an increasingly connected world as discussed in the article. It highlights the pervasive nature of chip technology central to Arm's growth trajectory. © metamorworks / Shutterstock.com

The 24/7 Wall St. price target for Arm (NASDAQ:ARM | ARM Price Prediction) is $273.77 over the next 12 months. Our model’s reference price is $287.64, so the target means -4.82% downside and a hold rating. Confidence is high.

An infographic titled 'ARM NASDAQ 12-Month Price Prediction' from 24/7 Wall St. displays a current reference price of $287.64 moving to a target of $273.77, a -4.82% change, resulting in a 'HOLD' rating with high confidence (90%). The section 'HOW WE GOT THERE' shows a final weighted base of $248.2, derived from a valuation blend including Forward P/E-Based at $208.13 (50% Weight). 'OUR ADJUSTMENTS' details a 247Factor Adjustment total of +1.103 with 50% dampening for Mega-Cap, leading to the final target of $273.77. Positive factors include Sector Momentum and Earnings Growth, while negative factors are Volatility Adjustment and neutral Sentiment. The 'BULL CASE' outlines potential positives like Neoverse shipments >1.5 billion cores and Hyperscaler CPU compute share ~50%, with a target of $417.9 (+45.28%). The 'BEAR CASE' lists risks such as Qualcomm litigation (Trial Q4 2026), China revenue dependence ($200M), and operating expenses surged 28%, with a target of $218.64 (-23.99%). The bottom line reiterates 'HOLD ($273.77, -4.82%)', stating valuation already prices in much data center growth and is near fair value.
24/7 Wall St.

24/7 Wall St. Price Target Summary

Metric Value
Current Price $287.64
Price Target: 24/7 Wall St. $273.77
Upside/Downside -4.82%
Recommendation HOLD
Confidence Level 90%

Arm has climbed to a valuation that already prices in much of its data center story. The data center is expected to soon become Arm’s largest business.

Demand for the Arm AGI CPU, its first in-house chip, now exceeds $2 billion. The stock also trades at 118x forward earnings, and that multiple is what keeps the target lower than the current share price.

ARM price target

Why We Could Be Wrong About Arm

The 24/7 Wall St. price target sits below where Arm trades today. AGI CPU orders could exceed the base opportunity. CEO Rene Haas said the CPU market estimate “may have been conservative.” Treat our target as one datapoint among many.

A 160% Rally Hits a Sharp Monday Pullback

Shares are up 159.78% year to date, 13.11% over the past month and 3.03% over the past week. Monday’s session cut 8.49%, with the stock trading near $283.97. That leaves Arm 36% below its 52-week high of $452.7 and far above its $100.02 low.

ARM price scenario

First-quarter fiscal 2027 revenue rose 22.4% to $1.29B, beating the $1.27B estimate. GAAP EPS of $0.25 missed expectations of $0.40. Non-GAAP EPS of 45 cents rose 29%. For the second quarter, management projects to $1.38 billion in revenue and $0.47 in non-GAAP EPS.

ARM earnings explorer

Why Bulls See $417.90 Within Reach

Arm Neoverse shipments have passed 1.5 billion cores, with 500 million shipped in nine months. Arm has about 50% of CPU compute share among top hyperscalers, each rolling out its own Arm-based chip.

Analysts expect EPS to climb from $2.2230 in fiscal 2027 to $3.0548 in fiscal 2028. Wall Street includes 7 Strong Buy and 20 Buy calls. The bull case hits $417.9, a 45.28% return.

ARM analyst ratings

What Could Drag Arm Toward $218.64

Arm’s trial against Qualcomm (NASDAQ:QCOM) is expected in Q4 2026. China revenue of $200M faces export controls. Operating expenses jumped 28% and operating margin narrowed to 7% from 11%.

Remaining performance obligations fell 7%. R&D spending of $838M funds silicon development. Operating cash flow rose 172%. The bear case lands at $218.64.

How Arm Compares to Qualcomm and NVIDIA

Company Trailing P/E Latest Quarter Revenue Growth
Arm 367 22.4%
Qualcomm 39 -4.03%
NVIDIA 45 105.85%

Qualcomm belongs here for three reasons: it licenses Arm’s technology, it is suing Arm, and it is moving into data center CPUs with the Arm-based Dragonfly C1000. Its handset revenue fell 20%, which explains its lower multiple.

NVIDIA (NASDAQ:NVDA) builds its Vera CPU on Arm and earns a 55.6% net margin versus Arm’s 18.4%, at a far lower multiple. Next to these peers, cutting Arm’s price looks reasonable.

Why Our Model Rates Arm a Hold for Now

24/7 Wall St.’s price target of $273.77 carries a hold rating at 90% confidence. Valuation is the key factor, as the rally has priced in much data center growth.

The case strengthens if AGI CPU gross margins rise from the high 30% range toward 50%. The case weakens if the Qualcomm trial or China rules hit royalties. At today’s price, Arm is fairly valued.

Looking further ahead, here is where our model projects Arm could trade, assuming current growth trends and market conditions hold.

Year Price Target: 24/7 Wall St.
2026 $282.41
2027 $294.94
2028 $279.96
2029 $270.97
2030 $273.97

Arm would need to keep executing on its current strategy for these projections to hold. The biggest swing factors are AGI CPU adoption and the Qualcomm litigation, which could move the stock well above or below these levels.

Contact [email protected] for any questions or corrections.

Vandita Jadeja

Vandita Jadeja is a financial publisher with over a decade of experience writing about financial topics, including investment, savings, retirement, insurance and banking. Vandita is a Chartered Accountant who loves to debunk financial concepts for readers.

Her work has appeared on sites that include The Motley Fool, InvestorPlace, and Benzinga. She covers investing and focuses on stock picks and price prediction for 24/7 Wall St.

When not looking for the next stock investment opportunity, she can be found traveling, reading, chasing sunsets and enjoying her iced latte.

All articles →